Member Info for Run1

Joules, ASOS and Sosander also down around 7%.
I can't imagine how this invasion will affect their sales.

I disagree that Llyod leaving would be a disaster. To quote from Laurel and Hardy "that's another fine mess you got us into".

There are other capable leaders out there ...

I think DX just wants to show the market that they're still around and doing things, albeit fairly mundane dressed loosely as innovation.

My calculations are along the same lines as your logic here.
Also, consider the time-lag from the purchase of the case to realisation - around 11 months if my memory serves me correctly. Quite a lag.

Omicron risk looks overblown. Christmas and New Year festivities are on.
Means alcoholic beverages.
Up 8% this morning, so far.

@Crazylaegs
Good thought IMO. I read today that Gymshark is opening its first store on Regent Street in 2022. They're no muggins. The best performing have both online and shops - Next and M&S for example.

On BOO, I have a buy set with a limit of 145p that expires on January 14th, 2022.

@stewie8

Expect it to bounce between 22p and 24p for a month or two before a) people who know about the raise forget about it, b) invested individuals get bored and try to trade it up and down, and c) new investors who don't do their homework are attracted by the price and story, d) there are few token investments by ANIC into fledgling businesses to spike a bit of interest.
The price then goes to 34p, as the NAV goes to 17p, hangs around thereabouts for a few months, drifts down to 28p at which point there's another fundraise.
Long term there will be billions of shares in issue, the brave early investors will be shafted and the latecomers will surf the late wave to great riches (2030 - 2035 AD).
This is what my crystal ball is telling me.

My gosh, these guys are good having their fingers in every pie and taking their cut left right and centre.

I halved my holding at 25.22p this morning, realising a 19% loss on those, and will ride with the balance.
I expect that Gatemore having a seat at the board table is now priced in, as are the seeds of recovery of investor confidence after the probable suspension.
Let's see.
GLA.

It riles me that when they should have been dealing with company business/investor relations they took the time to line their pockets.

Directors buying at low prices in the immediate (same day, in fact within hours) aftermath of an event caused by themselves, whether directly or indirectly, demonstrates moral flexibility, greed, and insensitivity to all those who do not have inside knowledge nevermind the personal wealth to buy more shares at the drop of a hat. What happened, IMO, with the Directors buys was a disgrace. Instead of being fully focused on the company business they were fiddling with their iphones buying shares in their own mess at knock-down prices.
If they wanted to reassure the markets they should have issued a detailed RNS with the traditional reassuring words that most PI's and all II's recognise as signals.
I really wanted to get that off my chest.

Thanks for your thoughts Blue83.
Given the timeframes you mention, it makes it more odd/interesting that the MD bought shares in July 2021, with knowledge then of the issue (if you are correct), at a price of around 32p. I really don't know what to make of that.

I think that the message in the RNS was pretty clear

Nope, out of the blue.

They wrongly assumed the product would pass muster? Big schoolboy error, needs looking into by regulators.

The issue goes beyond lost revenue. What do you do with an acquired company that cannot pass tech/quality requirements? It's a barrier to entry for a seat at the table in this business. Lives are at stake.
I'm 40% down so I'm not deramping but best to be realistic. Worst case Wendys becomes a recurring loss-making business - hence the strategic review, rather than a shrug and a "we will keep trying" type of message.

Many PIs don't have the patience, or financial ability to stay invested, to reap the rewards here. Buying now I think will yield a very attractive profit in 12 months. It is clear that case numbers will increase going forward but equally or more importantly the quality (yield) of cases accepted will improve as cases can be cherry-picked for profitability and time-to-completion.

Yes, there will be share price dips ahead - funds will be needed to fuel growth. There will be dilutions ahead at some points and let's hope that the company gives us loyal PIs a bite at the cherry.

I think that a takeover would be a bad scenario for holders here. The money is to be made by compounding %s over the next 3-5 years on an increasing share price. For me, at least, a one-time profit on a takeover event would be disappointing.

Do you know when the NAV is due?